Ftse Mib
36.719,35
1,38%
DAX
21.505,70
0,47%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
98.009,72
0,15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elicio Therapeutics Inc (ELTX) Elicio Therapeutics Inc (ELTX) Notizie

Elicio Therapeutics Inc

ELTX
9,22
0,30 (3,36%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/2/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202515:03EDGAR2Form 8-K - Current report
30/1/202514:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/1/202514:00GLOBEElicio Therapeutics Announces $10.0 Million Registered..
23/1/202522:36EDGAR2Form 8-K - Current report
22/1/202513:33EDGAR2Form 8-K - Current report
22/1/202513:30GLOBEElicio Therapeutics Reaches Alignment with FDA on ELI-002..
07/1/202522:30EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
18/12/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202413:05EDGAR2Form 8-K - Current report
12/12/202413:00GLOBEElicio Therapeutics Presents Updated Results from ELI-002..
03/12/202413:10EDGAR2Form 8-K - Current report
03/12/202413:00GLOBEElicio Therapeutics Announces Completion of Phase 2..
25/11/202413:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202413:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202414:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202422:06EDGAR2Form 8-K - Current report
13/11/202422:21EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202422:05GLOBEElicio Therapeutics Reports Third Quarter 2024 Financial..
07/11/202422:27EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEElicio Therapeutics Presents Updated Translational Data from..
07/11/202415:30EDGAR2Form 8-K - Current report
31/10/202413:30GLOBEElicio Therapeutics to Present Clinical Data at the Society..
17/10/202414:31EDGAR2Form 8-K - Current report
16/10/202414:30GLOBEElicio Therapeutics Reports Inducement Grants
02/10/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:41EDGAR2Form DEF 14A - Other definitive proxy statements
17/9/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17/9/202414:31GLOBEElicio Therapeutics Reports Inducement Grants
13/9/202414:30GLOBEElicio Therapeutics Announces Three Upcoming Presentations..
28/8/202414:00GLOBEElicio Therapeutics to Present at the H.C. Wainwright 26th..
13/8/202422:30GLOBEElicio Therapeutics Reports Second Quarter 2024 Financial..
12/8/202422:05GLOBEElicio Therapeutics Announces Closing of Private Placement..
28/6/202415:00GLOBEElicio Therapeutics Announces Pricing of $11.5 Million..
27/6/202422:05GLOBEElicio Therapeutics Announces Proposed Public Offering
27/6/202422:01GLOBEElicio Therapeutics Announces Preliminary Disease-Free..
18/6/202414:30GLOBEElicio Therapeutics Reports Inducement Grants
03/6/202423:24EDGAR2Form S-3 - Registration statement under Securities Act of..
03/6/202422:41EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/5/202423:30GLOBEElicio Therapeutics Announces Preliminary Data from the..
15/5/202422:34EDGAR2Form 8-K - Current report
15/5/202422:30GLOBEElicio Therapeutics Reports First Quarter 2024 Financial..
25/4/202414:30GLOBEElicio Therapeutics to Present New Preliminary Data from the..
05/4/202422:30GLOBEElicio Therapeutics to Present Updated Clinical T Cell and..
29/3/202413:30GLOBEElicio Therapeutics Reports 2023 Financial Results and..
18/3/202413:00GLOBEElicio Therapeutics Announces $6.0 Million Private Placement..
Apertura: 9,00 Min: 9,00 Max: 9,2945
Chiusura: 8,92

La tua Cronologia

NASDAQ
ELTX
Elicio Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci